| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 68.96B | — |
| Operating expense | — | — |
| Net income | 7.19B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, SZD.F returned +5.7% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -213.2% |
| 1 year | +5.7% |
| 5 years | +365.2% |
| 10 years | +15877383218918712.0% |
| All-time high | €17.60 (Jan 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in SZD.F would be worth today ›Yes. Santen Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.10 per share on Mar 30, 2026. The dividend yield is 2.31%.
Santen Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Santen Pharmaceutical Co., Ltd. has a market cap of 3.17B EUR, based on the latest quote.
Santen Pharmaceutical Co., Ltd. is scheduled to report earnings on Nov 5, 2026.
